Did you know?

Oct 17, 2023 · Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ:CRSP) to Neutral from Overweight, noting that its sickle cell therapy, exa-cel, in partnership with Vertex Pharmaceuticals Inc ... The CRSP US Stock Database contains end-of-day and month-end prices on all listed NYSE, Amex, and NASDAQ common stocks along with basic market indices, and ...CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).November 29, 2023 at 12:00 PM · 4 min read. Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, …Based on analysts offering 12 month price targets for CRSP in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your ...Jan 12, 2023 · Despite being founded 10 years ago, CRISPR Therapeutics (NASDAQ:CRSP) could very well lose out to 3-year-old Prime Medicine (NASDAQ:PRME). However that's in the long run. In the short term, CRSP ... Below is Validea's guru fundamental report for CRISPR THERAPEUTICS AG (CRSP). Of the 22 guru strategies we follow, CRSP rates highest using our Value Investor model based on the published strategy ...17 thg 8, 2023 ... Fintel reports that on August 17, 2023, Citigroup upgraded their outlook for CRISPR Therapeutics (NASDAQ:CRSP) from Neutral to Buy .NASDAQ: CRSP CRISPR Therapeutics. Market Cap. $5B. Today's Change (1.30%) $0.86. Current Price. $67.59. ... (CRSP 1.30%) ahead of a very big event for the gene editing company. In December, the U ...Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...1,264,745. 8.475509. Back to CRSP Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and ...The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?Dec 1, 2023 · 2. Ginkgo Bioworks. Ginkgo Bioworks has scaled up the process of engineering organisms that can be used in a variety of industries, from agriculture to pharmaceuticals. Through the company's ... ZUG, Switzerland and CAMBRIDGE, Mass., June 11, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...With Crispr Therapeutics Ag stock trading at $70.66 per share, the total value of Crispr Therapeutics Ag stock (market capitalization) is $5.61B. Crispr …Crispr Therapeutics AG Follow Share $69.09 After Hours: $69.12 (0.043%) +0.030 Closed: Nov 29, 6:14:27 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Intellia Therapeutics Inc $30.93...

The latest price target for CRISPR Therapeutics ( NASDAQ: CRSP) was reported by Morgan Stanley on Monday, November 13, 2023. The analyst firm set a price target for 42.00 expecting CRSP to fall to ...Jun 21, 2023 · An important moment may be only a few months away for CRISPR Therapeutics (NASDAQ: CRSP). I'm talking about the potential approval of its very first product. The U.S. Food and Drug Administration ... Download Historical Stock Quotes for Crispr Therapeutics Ag [NASDAQ,CRSP] in a range of formats.Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.

CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. [2] [3] The company has approximately 500 employees and has offices in Zug ...Jun 15, 2021 · As for price targets, the average analyst CRISPR price target is $160.75. Analyst price targets range from a low of $117.00 per share to a high of $189.00 per share. Bottom Line CRSP stock is ... …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Jan 31, 2023 · CRISPR Therapeutics (NASDAQ: CRSP) may be. Possible cause: Oct 31, 2023 · ZUG, Switzerland and BOSTON, Oct. 31, 2023 (GLOBE NEWSW.